Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Low zinc levels may be linked to the return of gynecologic cancers.

Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.

COVID-19 affects patients on chemotherapy for gynecological cancer negatively.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Scalp cooling reduces hair loss and improves quality of life during chemotherapy.

Chemotherapy reduces taste and smell, but they mostly recover after treatment; adding spices may help improve appetite.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

New skin lesions on the scrotum or vulva in patients with a history of internal cancer could indicate rare skin metastasis.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Sacituzumab Tirumotecan shows promise in treating gynecologic cancers with manageable side effects.

Chemotherapy provides symptom relief and extends life in 30-50% of gynecological cancer cases, but has only cured choriocarcinoma.

The article's findings are uncertain and should be viewed with caution.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

The issue covers reproductive health topics like cancer markers, incontinence treatments, and the impact of pre-term birth.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

2% Minoxidil does not prevent hair loss during chemotherapy.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Breast cancer patients should balance treatment with safe wellness practices to improve quality of life, consulting their oncologist first.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Chemotherapy is crucial for treating gynecological cancers but requires careful management due to severe side effects.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Further research is needed to develop effective cancer prevention strategies.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Most patients experienced significant but reversible hair loss during treatment.

Topical calcitriol is safe for preventing hair loss during chemotherapy.